Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Biogen · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
corneal endothelial cell loss, ocular pain, ocular inflammation, cataract surgery, rta 408, corneal endothelial cells, omaveloxolone, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 854559
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.